Klarquist was ranked among the top five firms nationwide for representing petitioners and patent owners in inter partes review disputes according to a recent case study by Patexia, an online patent research platform. These findings are based on a review of the performance and results obtained on the patent owner and petitioner sides of IPR proceedings.
Patexia noted that Klarquist represented petitioners in 37 IPR cases from 2012 through 2016. Klarquist prevailed in 30 of these cases, earning the firm an impressive 81% success rate and a ranking as one of the top five successful firms in the nation for representing petitioners before the Patent Trial and Appeal Board (PTAB). Additionally, Klarquist was ranked among the top five firms overall for representing both petitioners and patent owners in IPR disputes.
To see Patexia’s full list of top performing firms in IPR, click here.
Klarquist received top national rankings in the 2017 edition of Intellectual Asset Management (IAM) magazine’s IAM Patent 1000: The World’s Leading Patent Practitioners. Klarquist was once again recognized as the sole occupier of IAM Patent’s “Gold” top tier in Oregon.
Four Klarquist attorneys, Scott E. Davis, Jeffrey S. Love, William D. Noonan, M.D., and John D. Vandenberg, also received individual recognition. Additionally, Mr. Vandenberg was the only individual in Oregon recognized as “Highly Recommended” by the publication.
The IAM Patent 1000 includes top patent firms and professionals in key jurisdictions around the globe. The rankings are culled from extensive interviews and are based on depth of expertise, market presence, and the level of work on which attorneys are typically engaged. Read what IAM Patent and its sources had to say about us here.
Klarquist has received a top tier ranking from Chambers USA for 2017. Klarquist is recognized as one of two top tier intellectual property law firms in Oregon. In addition, three Klarquist attorneys, Scott E. Davis, William D. Noonan, M.D., and John D. Vandenberg, received individual recognition for intellectual property.
“You feel safe when a case is in their hands. They always perform, and they’re basically beyond compare with anyone else I have worked with in the country.”
“I love the firm. With every attorney I have worked with, I’ve had nothing but good experiences, and the people are quite impressive.“
Klarquist was recently recognized by TopVerdict.com for obtaining one of the top 50 highest jury verdicts in 2016 in California. It also was the highest verdict for a false advertising or Lanham Act claim.
On June 21, 2016, a jury in the Central District of California found CYME (a division of Eaton Corporation, represented by Jones Day) liable for making false claims about the performance of ETAP’s software. The jury awarded Klarquist’s client, ETAP, $8.42 million in damages, and found that CYME willfully engaged in false advertising. ETAP had been the victim of a three-year, worldwide smear campaign that started in June 2013. The campaign consisted of YouTube videos and emails distributed throughout the power system software industry. ETAP filed suit in June 2014, won summary judgment in March 2016 that the accused statements were literally false, and got a verdict that CYME is directly liable and responsible for the actions of its representative. The Klarquist team was led by Kristin Cleveland, Salumeh Loesch, Klaus Hamm, and John Vandenberg.
To see the full list of the Top 50 Verdicts in California for 2016, click here.
Klarquist has been ranked as one of the top trademark law firms in Oregon in the 2017 edition of World Trademark Review’s WTR 1000: The World’s Leading Trademark Professionals. Lisa M. Caldwell, Ramon A. Klitzke II, and Richard J. Polley also received individual recognition for being top individuals in their practice.
According to World Trademark Review, “Klarquist Sparkman delivers a pre-eminent full trademark service with very accommodating billing rates. It has a great IP reputation in Oregon and deals with big-ticket litigation; however, its prosecution practice is also a hub of strategic counselling excellence.”
Klarquist Sparkman, LLP was recognized as one of the nation’s “Best Law Firms” by U.S. News and Best Lawyers in its 2017 “Best Law Firms” survey.
Klarquist received metropolitan first-tier rankings in the following practice areas: Litigation – Intellectual Property; Litigation – Patent; Patent Law; and Trademark Law.
The rankings are based on an evaluation process that involves collecting client and attorney evaluations, peer reviews from leading attorneys in their field and review of additional information provided by law firms. Respondents were asked to rate firms based on expertise, responsiveness, understanding of a business and its needs, cost-effectiveness, civility and whether they would refer another client to the firm. All of the feedback is combined to create an overall score for each firm.
Klarquist Sparkman has been ranked among the Top Firms for Life Sciences Patents by Juristat, an intellectual property consulting firm. Klarquist ranked 4th nationwide for its success in obtaining patents for Life Science clients. Only 10 US firms were recognized, each of which had at least 100 patent applications that reached a final disposition in the relevant technology centers during the one-year period following the Myriad Supreme Court decision. The Myriad and Mayo decisions have made it significantly more difficult to obtain patents on life-sciences inventions, and have made patent prosecution in the life sciences practice groups (technology center 1600) at the USPTO more challenging. Juristat’s Top Firms for Life Sciences Patents list were ranked by their average allowance rates in technology center 1600. Klarquist’s high ranking demonstrates the firm’s expertise in prosecuting life science patents during a challenging time. “Our success demonstrates Klarquist’s expertise in advising clients, understanding the technology landscape, and efficiently working with patent examiners to advance the client’s case,” said Dr. William Noonan, who heads the firm’s Life Sciences Group. Click here to view the full Juristat report.
Klarquist was the only firm based in the Pacific Northwest to be ranked on the list of Top Firms for Life Sciences Patents. Klarquist is one of the largest intellectual property law firms in the Pacific Northwest, with more than 50 attorneys and patent agents. Eleven members of the firm’s Life Sciences Group hold either M.D.’s or Ph.D.’s in a range of science and technology fields, and many have also worked in or directed research laboratories. The firm handles patent matters for research institutions, universities, and large and small corporations located in the U.S. and throughout the world. The firm’s clients include biotechnology, chemical, medical device, software companies and research laboratories, such as Amazon.com, Inc., Centers for Disease Control and Prevention, Emory University, National Institutes of Health, University of Pittsburgh, Microsoft, GE Healthcare, Mentor Graphics, TriQuint Semiconductors, Salk Institute for Biological Studies, and Ventana Medical Systems, Inc.
For additional information please contact Dr. William D. Noonan at (503) 595-5300 or firstname.lastname@example.org.
The U.S. Food and Drug Administration (FDA) was recently awarded the United States Patent and Trademark Office’s 2016 Patents For Humanity award for their work developing an improved meningitis vaccine production process. The patented technology has led to the MenAfriVac® vaccine, and more than 235 million people in Africa’s high-risk meningitis belt have been immunized with it since 2010. Unlike previous vaccines, the new technology created by the FDA raised the vaccine production yield from 20% to 60% and enabled the vaccine to last up to four days without refrigeration. The FDA has licensed the technology to the Meningitis Vaccine Program (MVP) and hosted production scientists from MVP’s Indian manufacturer to teach them how to use the vaccine production technology.
Only four cases of meningitis A were reported in 2013 in the immunized region covering 16 countries. In 2015, the World Health Organization recommended that MenAfriVac® be introduced in routine immunization schedules in sub-Saharan Africa. This will ensure that infants are protected against meningitis and will maintain population-wide immunity.
The Life Sciences team at Klarquist, led by William D. Noonan, M.D., works with the FDA to manage their patent portfolio. Wayne Rupert and Susan Graf, Ph.D. successfully prosecuted patent applications for the FDA’s Polysaccharide-Protein Conjugate Vaccine invention that led to the MenAfriVac® vaccine.
Klarquist is proud to have six attorneys named to the 2017 Best Lawyers in America® list: Lisa M. Caldwell in the area of Trademark Law; James E. Geringer in the areas of IP Litigation, Patent Litigation, and Trademark Law; Ramon A. Klitzke II in the areas of Patent Law and Trademark Law; William D. Noonan, M.D. in the area of Patent Law; Stacey C. Slater in the area of Patent Law; and John D. Vandenberg in the areas of IP Litigation and Patent Litigation. In addition, Mr. Klitzke was recognized as the Patent Law “Lawyer of the Year” in Portland, OR.
Best Lawyers® compiles its lists of attorneys by conducting peer-review surveys in which thousands of leading lawyers confidentially evaluate their professional peers. Only a single lawyer in each practice area and in each community surveyed is selected as a Lawyer of the Year. The Best Lawyers in America® can be found online at www.bestlawyers.com.
Klarquist is proud to have Ramon A. Klitzke II, Jeffrey S. Love, and John D. Vandenberg named to the 2016 Oregon Super Lawyers® list, and Carla Todenhagen selected for inclusion on the 2016 Oregon Rising Stars℠ list.
The annual survey is published by Thomas Reuters. Surveys of attorneys throughout the country as well as in depth research and peer reviews are used to complete the selection process. Super Lawyers can be found online at www.superlawyers.com.